Bebo Health (XPAR:MLBBO) Other Financing: €0.00 Mil (TTM As of Dec. 2025)


XPAR:MLBBO Bebo Health SA XPAR:MLBBO
47 GF Score
Price €0.23
GF Value €0.03
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bebo Health Other Financing?

Bebo Health XPAR:MLBBO 47 Other Financing is €0.00 Mil as of Dec. 2025. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Bebo Health's Other Financing for the six months ended in Dec. 2025 was €0.00 Mil.

Bebo Health's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Bebo Health Other Financing Historical Data

* Premium members only.

The historical data trend for Bebo Health's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bebo Health Other Financing Chart

Bebo Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Bebo Health Semi-Annual Data
Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
XPAR:MLBBO
47GF Score
Bebo Health SA XPAR:MLBBO
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bebo Health Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €0.00 Mil mean?
Bebo Health (XPAR:MLBBO) has a Other Financing of €0.00 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Bebo Health and its competitors.
Is Bebo Health's Other Financing too high?
Bebo Health's current Other Financing is €0.00 Mil. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's Other Financing compare to CASY and WSM?
Bebo Health's Other Financing of €0.00 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Retail - Cyclical company?
A good Other Financing depends on the Retail - Cyclical industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Bebo Health and its competitors. Bebo Health's current Other Financing is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.23 — trading 660% above its estimated fair value. The current Other Financing is €0.00 Mil. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current Other Financing is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?

Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued. The current stock price of €0.23 is trading 660% above its estimated GF Value™ of €0.03. GuruFocus considers Bebo Health to be Significantly Overvalued.

Key valuation signals for XPAR:MLBBO:

  • Other Financing: €0.00 Mil
  • GF Value™: €0.03 vs. price of €0.23 (660% above fair value)
  • GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bebo Health Business Description

Address 1 Rue de la Cite, Geneve, CHE, 1204
Bebo Health SA is a multilingual e-commerce portal specializing in products dedicated to health, sport and wellness.
47GF Score

Get the complete analysis for XPAR:MLBBO

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.23
Price
€0.03
GF Value